Aflac Exits U.S. Medicare Supplement Market After Missing Goals

Aflac Inc., the insurer that gets most of its sales in Japan, is withdrawing from the U.S. Medicare supplement market after results fell short of goals in the first year.

“We determined that the product did not meet our sales targets and profit objectives,” Chief Executive Officer Dan Amos said today in an e-mailed statement. “Therefore we decided to discontinue it.”

To contact the reporter on this story: Zachary Tracer in New York at

To contact the editor responsible for this story: Dan Kraut at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.